Company News

Stay up to date on the exciting events that happen with Tower MSA and our industry.

The DEA Finally Decides To Reschedule Hydrocodone

Posted on August 27, 2014 by Tower MSA

Last week the DEA released a final rule on the rescheduling of hydrocodone removing it from the schedule III controlled substances list in favor of a schedule II designation. To be clear, this decision specifically addresses hydrocodone combination products (i.e.,…

Read more

New Additions to Tower Executive Team

Posted on August 13, 2014 by Rita Wilson

In our continued commitment  to build a unique MSP compliance model focused on  identification, intervention and involvement to stage claims prior to MSA and settlement, I am pleased to announce the addition of two key individuals to the Tower MSA Partners…

Read more